期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JAPANESE JOURNAL OF CLINICAL ONCOLOGY LetPub Score 5.3
50 ratings
Rate
Reputation 6.4 Influence 4.0 Speed 7.1 | ||||||||||||||||||||||||
期刊簡稱 | JPN J CLIN ONCOL | ||||||||||||||||||||||||
ISSN | 0368-2811 | ||||||||||||||||||||||||
E-ISSN | 1465-3621 | ||||||||||||||||||||||||
h-index | 79 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 15.80%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://academic.oup.com/jjco | ||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/jjco | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Oxford University Press | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | JAPAN | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1971 | ||||||||||||||||||||||||
每年文章數 | 155每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 17.38% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0368-2811%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[JAPANESE JOURNAL OF CLINICAL ONCOLOGY] 的評論 | 撰寫評論 |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-18 22:42:23 評論於 Waiting for the chief editor's decision refers to the status where the editor has consolidated all the opinions of the reviewers and the chief editor makes the final decision.(0) 讚! | Adelaide Lawson |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-18 13:46:02 評論於 Good luck, the decision from the chief editor is not far away, please be patient and wait.(0) 讚! | Adelaide Lawson |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-18 08:37:16 評論於 While waiting for the editor-in-chief to make a decision, the next stage is not far off. Pay close attention to the status of your submission.(0) 讚! | Adelaide Lawson |
作者: Julius Sinclair 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-16 18:42:48 評論於 A few days ago I was awaiting AE decision, today it has changed to awaiting EIC decision. Nervous.(0) 讚! | Julius Sinclair |
作者: Julius Sinclair 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-16 12:46:26 評論於 Hello, I would like to ask what does the status "waiting EIC decision" mean?(0) 讚! | Julius Sinclair |
作者: Julius Sinclair 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-16 08:25:41 評論於 After AE's decision, it has been changed to "awaiting EIC decision". Is there a high possibility of being hired, or will it require revisions?(0) 讚! | Julius Sinclair |
作者: Julius Sinclair 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-15 08:15:23 評論於 Today I saw that it has already been Waiting AE recommendation, please accept ??(0) 讚! | Julius Sinclair |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-01 22:52:58 評論於 The review period of this journal is generally around 3-8 weeks. You are only about 2 weeks in, so being "Under Review" is within the normal range.(0) 讚! | Adelaide Lawson |
作者: Julius Sinclair 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-01 19:47:02 評論於 What does it mean when it says "under review" after submitting, with three EO written? Is it under review or still in the hands of the editor?(0) 讚! | Julius Sinclair |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-01 12:42:45 評論於 This may indicate that the editor has invited three reviewers to evaluate your manuscript, but does not mean it has been sent out for external peer review.(0) 讚! | Adelaide Lawson |
作者: Julius Sinclair 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-27 20:30:13 評論於 Research focus: Tumors; Cancer Experience sharing: Submitted on August 19, 2024, still under review, with 3 reviewers.(0) 讚! | Julius Sinclair |
作者: 木子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-04 17:39:17 評論於 Is there a charge for this?(0) 讚! | 木子 |
作者: Jiang Huihui 領域: 医学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2024-06-22 19:30:48 評論於 Rejected after major revision, the magazine said their acceptance rate is only 20%.(0) 讚! | Jiang Huihui |
作者: 思茵来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-02 12:12:16 評論於 Please translate the following paragraph into English: 接accept(0) 讚! | 思茵来了 |
作者: 北风成文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-03 17:00:54 評論於 Where has the author submitted now?(0) 讚! | 北风成文 |
作者: 小新真吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-26 16:46:52 評論於 Review speed: 6.0 | Submission acceptance rate: 50.0 Research focus: Nutrition; Experience sharing in gastrointestinal surgery: 4.19 submit 6.11 minor revision 8.3 major revision 8.24 minor revision 8.25 major revision 9.25 acceptance. During the process, the status of "awaiting AE recommendation" is most common, and the efficiency is generally average(0) 讚! | 小新真吖 |
作者: 一条小友容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-28 11:41:29 評論於 Have you repeatedly received the following emails when returning for rework?(0) 讚! | 一条小友容 |
作者: 一条小友容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-28 10:28:38 評論於 Can I ask why we always receive emails saying the quality inspection is not correct when we send items for repair?(0) 讚! | 一条小友容 |
作者: 白云又菡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-24 23:52:55 評論於 Submitted a case, was rejected decisively... They said the priority level of the article was not enough. It's so hard to submit cases now, either it's a journal that gets flagged for warnings, or it's not SCI, or it's a comprehensive journal that can only publish a few cases a year, mostly domestic cases... I really don't understand why they flagged world cases... It's making it so difficult to submit cases(0) 讚! | 白云又菡 |
作者: 孤云静晨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-25 10:44:37 評論於 It has been almost a month and I am still crying in AE(0) 讚! | 孤云静晨 |
作者: 重阳庆庆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-22 09:40:18 評論於 +1, do you accept meta?(0) 讚! | 重阳庆庆 |
作者: Miranda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-18 10:41:20 評論於 Focused Research Area: Cancer; Tumor Experience Sharing: Are there any experts willing to share their experiences on submitting to this journal?(0) 讚! | Miranda |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:32:45 評論於 The title of the paper should be concise and not too long. The shorter the better, while accurately reflecting and clearly expressing the most important specific content. Try to avoid unnecessary words, delete excess words as much as possible. Short paper titles generally have higher citation rates(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:51:48 評論於 Today is a beautiful day, I will go for a walk in the park(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 23:29:03 評論於 How many words are usually required for the title of an article?(0) 讚! | 陶宜三岁啦 |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us